Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study-Reference-Cited by-同舟云学术

Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

Published:2011-04-09 Issue:6 Volume:68 Page:1439-1447
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Leal Ticiana B.,Remick Scot C.,Takimoto Chris H.,Ramanathan Ramesh K.,Davies Angela,Egorin Merrill J.,Hamilton Anne,LoRusso Patricia A.,Shibata Stephen,Lenz Heinz-Josef,Mier James,Sarantopoulos John,Mani Sridhar,Wright John J.,Ivy S. Percy,Neuwirth Rachel,von Moltke Lisa,Venkatakrishnan Karthik,Mulkerin Daniel

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1637-5.pdf

Reference27 articles.

1. Goldberg AL, Akopian TN, Kisselev AF et al (1997) New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol Chem 378:131–140

2. Zwickl P, Baumeister W, Steven A (2000) Dis-assembly lines: the proteosome and related ATPase-assisted proteases. Curr Opin Struct Biol 10:242–250

3. Ciechanover A, Orian A, Schwartz AL (2000) Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22:442–451

4. Hershko A (1997) Roles of ubiquitin -mediated proteolysis in cell cycle control. Curr Opin Struct Biol 9:788–799

5. Oikawa T, Sasaki T, Nakamura M et al (1998) The proteasome is involved in angiogenesis. Biochem Biophys Res Commun 246:243–248

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A model‐assisted design for partially or completely ordered groups;Pharmaceutical Statistics;2024-05-20

2. Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma;Blood Reviews;2023-09

3. Bortezomib Increased Vascular Permeability by Decreasing Cell–Cell Junction Molecules in Human Pulmonary Microvascular Endothelial Cells;International Journal of Molecular Sciences;2023-06-29

4. Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management;Cureus;2022-02-25

5. Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations;Biomolecules;2021-12-30